Differential proteomic techniques continue to be pivotal in biomarker discovery, and serve as a leading role in biomarker development. In this article, several widely recognized differential proteomic platforms are surveyed. These platforms usually involve either gel electrophoresis or liquid chromatography for separation, and combine isotope labeling with mass spectrometric analysis for identification and quantification. Furthermore, each approach has advantages and disadvantages from the conceptual and the methodological viewpoints. The ultimate goal of differential proteomics is to discover and to identify protein marker in different physiological or pathological states. A successful biomarker development not only depends on biomarker discovery but also relies on biomarker validation. Incorporating knowledge from other disciplines, biomarker development for useful and valid clinical applications is highly expectable.